|
⚲
|
| Miragen Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001417827 |
| Sale | 2008-05-16 ($12.0 M Offered, $12.0 M Sold) |
| Fund | |
| Phone | 3035315952 |
| Address | 6200 Lookout Road Boulder, 80301 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Kyle Lefkoff | |
| Bruce Booth | |
| William Marshall | |
| Marvin Caruthers |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Iterative Capital LLC
✚
|
0.0 | |
|
5:01 Acquisition LLC
✚
|
0.0 | |
|
Pasternack Bruce A
✚
|
0.0 | |
|
Jetha Global DIFC Ltd
✚
|
0.0 | |
|
CIT 098, a series of SAX Capital Series Fund III, LP
✚
|
0.0 | |
|
CW Gas Partners II, L.P.
✚
|
0.0 | |
|
Lafaille Stephen
✚
|
0.0 | |
|
Moussa Robert G
✚
|
0.0 | |
|
Mouton Kent Y
✚
|
0.0 | |
|
KA-1214 Fund I, a series of SaxeCap, LP
✚
|
0.0 |